Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Amphetamine and Naltrexone

supplement:

Amphetamine

Research Papers that Mention the Interaction

Pretreatment with naltrexone significantly attenuated the subjective effects of amphetamine (P < 0.05), and this effect was time-dependent with a reduction from the 3-hour time point.
The results provide preliminary evidence that naltrexone may reduce the reinforcing effects of amphetamine via modulation of the opioid system.
Journal of clinical psychopharmacology  •  2004  |  View Paper
However, in a chronic model, naltrexone significantly attenuated the dopamine release caused by reinstatement of amphetamine.
In healthy humans, naltrexone attenuated the subjective effects of amphetamine , confirming our previous results.
The opioid antagonist naltrexone has been shown to attenuate the subjective effects of amphetamine.
We hypothesized that naltrexone would diminish the striatal dopamine release induced by amphetamine , which is considered an important mechanism behind many of its stimulant properties.
Translational Psychiatry  •  2017  |  View Paper
Compared to placebo, the abstinence rate was increased significantly (p < 0.05) by naltrexone in one of two amfetamine studies , whereas there was no statistical difference in the only study reporting methamfetamine use.
Clinical toxicology  •  2019  |  View Paper
Early-phase human studies suggested naltrexone reduced amphetamine use among dependent individuals.
Addiction  •  2018  |  View Paper
Naltrexone and bupropion, when administered alone in clinical trials, modestly reduce amphetamine use.
Pharmacology Biochemistry and Behavior  •  2015  |  View Paper
RationaleOpioid antagonists (e.g., naltrexone ) and positive modulators of γ-aminobutyric-acidA (GABAA) receptors (e.g., alprazolam) modestly attenuate the abuse-related effects of stimulants like amphetamine.
Psychopharmacology  •  2014  |  View Paper
Both preclinical and clinical studies suggest that the opioid antagonist naltrexone NTX ) is effective in reducing the abuse liability of amphetamine , raising the question of whether similar positive findings would be obtained for cocaine.
Neuropsychopharmacology  •  2013  |  View Paper
Recent human laboratory studies have demonstrated that naltrexone modulates some of the reinforcing effects of amphetamine.
The American journal of psychiatry  •  2008  |  View Paper
Co-administration of naltrexone may selectively enhance amphetamine potency to decrease cocaine choice without increasing amphetamine potency to produce general behavioral disruption.
Drug and alcohol dependence  •  2017  |  View Paper
The unselective opioid receptor antagonist naltrexone NTX ) modulates amphetamine‐induced effects in both laboratory animals and humans.
Addiction biology  •  2011  |  View Paper
Show More